HD-OPM Archive
Topics › Statins

Statins for 3+ years linked to 63% lower dementia risk in a 55-study meta-analysis

Louis Nervegna · Feb 12, 2025 · ♥ 22 reactions · 20 comments · original Facebook post
StatinsBrain health & dementia
AI summary & key facts

Louis shares a news report of a Brazilian meta-analysis of 55 observational studies with about 7 million patients. Staying on statins for at least three years was associated with 63% lower dementia risk; the STAREE and PREVENTABLE trials should clarify causality.

Cholesterol-Lowering Statins May Reduce Dementia Risk by 63%

Quoted:

“A new meta-analysis out of Brazil might hold some clues. Using data from 55 observational studies and 7 million patients, the research team found that taking statins was associated with a lower risk of developing Alzheimer’s disease and dementia.”

“According to the study, people who stayed on statins for at least three years had a 63% reduction in dementia risk. These findings suggest people may need to stay on the drugs long-term for significant cognitive protection, he added.”

“Two ongoing clinical trials–STAREE and PREVENTABLE—will help researchers better understand how statins directly influence dementia risk.

Thousands of participants have been enrolled in both trials and cognitive harm is “very unlikely” since data safety monitoring boards have not stopped either study for this reason, said Alexander, the principal investigator of the PREVENTABLE study.

“Stay tuned in the coming two to three years for more information coming from these likely definitive studies,” she said.”

#statinsHD #dementiaHD #ldlHD #statinsdementiaHD #ldldementiaHD #alzheimersHD

Verywell HealthCholesterol-Lowering Statins May Reduce Dementia Risk by 63%, Study SaysA new meta-analysis tackles the ongoing scientific question: are statins linked to dementia risk?verywellhealth.com

Research cited

← newer: Video series surveys ages at death of over 100 health influeolder: Nobel story of artemisinin and natural-product drug origins →